TDP-43

PASADENA, Calif., April 28, 2026 AcuraStem has received $7.5 million in grant funding from the California Institute for Regenerative...

AMSTERDAM, Netherlands & BOSTON, Massachusetts, USA, April 28, 2026 VectorY Therapeutics has announced that it has received authorization from...

Amsterdam, The Netherlands, and Boston, MA — January 8, 2026 — VectorY Therapeutics announced that the U.S. Food and...